Another Record Year for US Generic Drug Approvals in 2017
By Zachary Brennan -
Published 05 October 2017
The US Food and Drug Administration (FDA) has approved more abbreviated new drug application (ANDA) in 2017 than any other year, according to the latest FY 2017 activities report.
Categories: News, US, CDER, Generic drugs, Regulatory intelligence, Regulatory strategy
Tags: generic drug approvals, GDUFA, 2017 generic drug approvals